Multidisciplinary Treatment of Patients with Progressive Biliary Tract Cancer after First-Line Gemcitabine and Cisplatin: A Single-Center Experience.

Müller, Christian; Omari, Jazan; Mohnike, Konrad; Bär, Caroline; Pech, Maciej; Keitel, Verena; Venerito, Marino

Müller, Christian; Omari, Jazan; Mohnike, Konrad; Bär, Caroline; Pech, Maciej; Keitel, Verena; Venerito, Marino.

Affiliation

Müller C; Department of Gastroenterology, Hepatology and Infectious Diseases, Otto-von-Guericke University Hospital, 39120 Magdeburg, Germany.
Omari J; Department of Radiology and Nuclear Medicine, Otto-von-Guericke University Hospital, 39120 Magdeburg, Germany.
Mohnike K; DTZ Diagnostic and Therapeutic Center, 10243 Berlin, Germany.
Bär C; Department of Radiology and Nuclear Medicine, Otto-von-Guericke University Hospital, 39120 Magdeburg, Germany.
Pech M; Department of Radiology and Nuclear Medicine, Otto-von-Guericke University Hospital, 39120 Magdeburg, Germany.
Keitel V; Department of Gastroenterology, Hepatology and Infectious Diseases, Otto-von-Guericke University Hospital, 39120 Magdeburg, Germany.
Venerito M; Department of Gastroenterology, Hepatology and Infectious Diseases, Otto-von-Guericke University Hospital, 39120 Magdeburg, Germany.

Cancers (Basel) ; 15(9)2023 May 03.

Article de En | MEDLINE | ID: mdl-37174064

Mots clés

FOLFIRI; biliary tract cancer; cholangiocarcinoma; minimal invasive therapy; multidisciplinary treatment; second-line

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Qualitative_research Langue: En Journal: Cancers (Basel) Année: 2023 Type de document: Article Pays d'affiliation: Allemagne Pays de publication: Suisse

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google